Teitur Trophics
- Biotech or pharma, therapeutic R&D
More than 200 million patients suffer from neurodegenerative disorders world-wide. Today, no treatments are available to prevent the relentless progression of neurodegeneration, affecting memory, movement and quality of life for them and their loved ones.
From the Sortilins family of receptors, Teitur has developed cyclic peptides with a unique potential for addressing key pathologies across several neurodegenerative disorders including Huntington’s Disease, Parkinson’s Disease and Frontotemporal Dementia. These diseases impact memory, behaviour, movement and mood of millions of people around the globe.
Teitur is Old Norse for happiness. Our ambition and commitment is to create new treatments for patients suffering from neurodegenerative diseases to help them live a longer, better and happier life.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}